Skip to main content
PFE
NYSE Life Sciences

Pfizer Posts 56-Cent Q3 EPS as Shares Sit at 52-Week High

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$30.98
Mkt Cap
$174.809B
52W Low
$23.62
52W High
$31.04
52W Position info
31% above low
Off High info
at 52W high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

PFE sits 31% above its 52-week low of $23.62.

Summary

Pfizer reported third-quarter 2026 revenue of $16.58B and adjusted EPS of 87 cents, alongside GAAP EPS of 56 cents. The company raised its 2026 guidance, now seeing full-year adjusted EPS of $2.95 to $3.05 and revenue of $62B to $64B, up from its prior revenue outlook of $60.5B to $62.5B. The print lands with the stock at $30.98, just under its 52-week high of $31.04, so expectations are already elevated. Context matters here: the prior quarter (Q2 2026) was a $248 million net loss driven by $4.3 billion in asset impairments, alongside $2.5 billion of additional cost savings and a zero-tariff agreement with the U.S. government. The pipeline has also been busy — FDA approval of the updated COVID vaccine, Phase 2 win for tilrekimig, the Metsera acquisition adding a monthly GLP-1, and TUKYSA's approval — but a Florida AG lawsuit against the company and CEO Albert Bourla over marketing is an overhang.

Updates

  1. · Reuters — Pfizer's Q3 revenue of $16.58 bln beat the $15.87 bln consensus and adjusted EPS of $0.87 beat $0.73; 2026 adjusted EPS guidance is $2.95-$3.05.

At the time of this announcement, PFE was trading at $30.98 on NYSE in the Life Sciences sector, with a market capitalization of approximately $174.8B. The 52-week trading range was $23.62 to $31.04. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 18, 2026, 7:20 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.28
Real-time Price: $27.86 info
Change: -$0.420 (-1%) info
Market Cap: $159.938B info
PFE
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.12
Real-time Price: $27.86 info
Change: -$1.26 (-4%) info
Market Cap: $159.938B info
PFE
Nov 13, 2026, 3:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $28.85
Real-time Price: $27.86 info
Change: -$0.9925 (-3%) info
Market Cap: $159.938B info
PFE
Nov 11, 2026, 4:30 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.45
Real-time Price: $27.86 info
Change: -$1.59 (-5%) info
Market Cap: $159.938B info
PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $27.86 info
Change: -$2.80 (-9%) info
Market Cap: $159.938B info